The Ibuprofen API Market is experiencing gradual growth as demand for ibuprofen-based pharmaceutical products remains strong across pain management, fever reduction, and inflammation treatment. The market is expected to reach US$ 842.27 Million by 2034, rising from US$ 787.84 Million in 2025, and is estimated to record a CAGR of 0.84% from 2026 to 2034. Continued demand...